Europe — EMA

Onkotrone (Mitoxantrone Hydrochloride)

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an antineoplastic agent presented as a sterile lyophilised powder for intravenous infusion use.

Mitoxantrone Hydrochloride

Request sourcing

Pack/s

What is Mitoxantrone Hydrochloride?

Mitoxantrone Hydrochloride, the active ingredient in Onkotrone, is an antineoplastic agent presented as a sterile lyophilised powder for intravenous infusion use. It is employed in the treatment of certain malignancies such as acute‑type acute myeloid leuka d (AML) and ... .... ... .... .... ... ... .

GNH USA supplies Onkotrone as a licensed ... .... ... ... ... ... … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … … .

What is Mitoxantrone Hydrochloride used for?

Onkotrue .... .... ... ... ... .... .... ... ... .... ...

What are the side effects of Mitoxantrone Hydrochloride?

Common ...

What precautions apply to Mitoxantrone Hydrochloride?

...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →